Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
22.94 USD | -0.65% | +4.84% | -24.01% |
Jun. 03 | Intellia Therapeutics Shares Rise as NTLA-2002 Phase 1 Study Observes 98% Mean Reduction in Monthly Attack Rate | MT |
Jun. 03 | Transcript : Intellia Therapeutics, Inc. - Special Call |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-24.01% | 2.23B | |
+57.44% | 59.34B | |
+43.17% | 40.24B | |
-4.87% | 39.88B | |
-5.56% | 28.55B | |
+15.07% | 27.26B | |
-21.04% | 19.23B | |
+32.60% | 12.61B | |
+2.59% | 12.49B | |
+25.92% | 12.28B |
- Stock Market
- Equities
- NTLA Stock
- News Intellia Therapeutics, Inc.
- Intellia Therapeutics' Q1 Net Loss Narrows, Collaboration Revenue Rises